The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Alirocumab plus cemiplimab in immuno-refractory metastatic NSCLC: A single-arm, multi-center, phase 2 study.
 
Eziafa Oduah
Consulting or Advisory Role - Roche
Research Funding - Bristol-Myers Squibb Foundation/Janssen; Johnson & Johnson (Inst); OncoC4 (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - DAVA Oncology
 
Andreas Saltos
Honoraria - HealthCentral; IDEOlogy Health; MJH Life Sciences; MJH Life Sciences (I)
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Daiichi Sankyo/Astra Zeneca; Janssen; Pfizer
Research Funding - Bayer (Inst); BioAtla (Inst); BioNTech SE (Inst); Daiichi Sankyo (Inst); Genentech (Inst); ImmunityBio (Inst); Janssen (Inst); Kalivir Immunotherapeutics (Inst); Lilly (Inst); Memgen (Inst); NGM Biopharmaceuticals (Inst); Novartis (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Dava Oncology
 
Tom Stinchcombe
Consulting or Advisory Role - Boehringer Ingelheim; Coherus Biosciences; Gilead Sciences; Janssen Oncology; Pfizer; Takeda
Research Funding - Boehringer Ingelheim (Inst); Mirati Therapeutics (Inst); Nuvalent, Inc. (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Pfizer
Other Relationship - Genentech; GlaxoSmithKline; Merck; Pfizer
 
Joel Rivera Concepcion
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb Foundation; Genentech
Travel, Accommodations, Expenses - EMD Serono/Merck
 
Jeffrey Crawford
Consulting or Advisory Role - Actmed; BioAtla; Faraday Pharmaceuticals; G1 Therapeutics; Pfizer; Tensegrity
Research Funding - AstraZeneca (Inst); Helsinn Healthcare (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Jeffrey Clarke
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Corbus; G1 Therapeutics; Genentech; Merck; Novartis; Pfizer; Sanofi; Spectrum Pharmaceuticals; Turning Point Therapeutics; Vivacitas Oncology
Speakers' Bureau - Amgen; AstraZeneca
Research Funding - Achilles Therapeutics (Inst); Adaptimmune (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cellular Biomedicine Group (Inst); Genentech (Inst); Grid Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen
(OPTIONAL) Uncompensated Relationships - Lung Cancer Initiative of North Carolina
 
Laura Alder
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim; Foundation One Inc; MJH Life Sciences; NuvationBio; OncoHost; Regeneron
Research Funding - BerGenBio; Iambic Pharmaceuticals; ORIC Pharmaceuticals; Phanes Therapeutics
 
Cameron Oswalt
Honoraria - Aptitude Health; Cardinal Health; Charles River Associates; DAVA Pharmaceuticals; IDEOlogy Health; MJH Life Sciences; Nuvation Bio; OncLive/MJH Life Sciences; Oncohost
Consulting or Advisory Role - Cardinal Health; Nuvation Bio
Travel, Accommodations, Expenses - Cardinal Health
 
Steven Wolf
No Relationships to Disclose
 
Sin-Ho Jung
No Relationships to Disclose
 
Kouros Owzar
No Relationships to Disclose
 
Xiaodi Qin
No Relationships to Disclose
 
Abbie Ireland
No Relationships to Disclose
 
Alan Chen
No Relationships to Disclose
 
Liliana Lyniv
No Relationships to Disclose
 
Neal Ready
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; Bristol Myers Squibb Foundation; Celgene; G1 Therapeutics; Johnson & Johnson/Janssen; Merck; Merck Serono; novartis; Pfizer; Zai Lab
Speakers' Bureau - Bristol-Myers Squibb; Jazz Pharmaceuticals
Research Funding - Memgen (Inst); Merck; Regeneron (Inst)
 
Jhanelle Gray
Honoraria - Amgen; AstraZeneca; CatalYM; Coherus Biosciences; Daiichi Sankyo, Inc; Flatiron Health; Genentech; Gilead Sciences; GO2 for Lung Cancer; IDEOlogy Health; Janssen Scientific Affairs; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Lilly; Merck; Novartis; Pfizer; Regeneron; Takeda; Zai Lab
Consulting or Advisory Role - Amgen; AstraZeneca; Catalym; Coherus Biosciences; Daiichi Sankyo/UCB Japan; Flatiron Health; Genentech; Gilead Sciences; GO2 for Lung Cancer; IDEOlogy Health; Janssen Scientific Affairs; Jazz Pharmaceuticals; Lilly; Merck; Novartis; Pfizer; Regeneron; Takeda; Zai Lab
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Catalym (Inst); Genentech (Inst); Gilead Services (Inst); GO2 for Lung Cancer (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Panbela Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Abbvie
 
Trudy Oliver
Honoraria - Illumina; OncLive Clinical Congress Consultants; Pfizer
Patents, Royalties, Other Intellectual Property - Methods and compositions for identifying and treating patients with small cell lung cancer
Travel, Accommodations, Expenses - Pfizer
 
Scott Antonia
Consulting or Advisory Role - Achilles Therapeutics; Guardian Bio; Immutep; Leap Therapeutics; Memgen; RAPT Therapeutics; Shoreline; Tubulis GmbH; xilis
Patents, Royalties, Other Intellectual Property - Oncolytic virus